You are currently logged into
Cancer Health Directory - My Account or Log Out
Cancer Health Cancer Health
  • Home
  • News
    • News
    • Newsfeed
    • Science News
    • Features
    • Opinions
    • Conferences
    • Slideshows
    • Cancer Health TV
    • By Author
    • RSS Links
  • Cancer Basics
    • Cancer 101
    • Newly Diagnosed
    • Living with Cancer
    • Cancer Treatment
    • Cancer Medications
    • Breast Cancer
    • Colon Cancer
    • Liver Cancer
    • Lung Cancer
    • Prostate Cancer
    • More Types of Cancer
    • Resources
  • Hot Topics
    • Coronavirus (COVID-19)
    • Health Equity
    • Cancer Treatment
    • Car-T Therapy
    • Caregivers
    • Chemotherapy
    • Immunotherapy
    • Marijuana
    • Mental Health
    • Quality of Life
  • Magazine
    • Magazine
    • Current Issue
    • Archives
    • Digital Editions
    • Cancer Health Focus
    • Bulk Subscriptions
    • Email Newsletters
  • Blogs
    • Blogs
    • Recent Posts
    • Browse Bloggers
    • RSS Links
  • Community
    • Cancer Health Stories
    • Cancer Health Forums
    • Ask Cancer Health
    • Polls
    • Surveys
    • Quizzes
    • Calendar
    • Volunteer Jobs
    • Bookstore
    • Amazon Store
  • About Us
    • About Us
    • Masthead
    • Advertise
    • Awards
    • Contact Us
  • Facebook
  • Twitter

© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2021 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement

Share


Twitter
Facebook
Pinterest
Tumblr
Email

#Nexavar

Tweet
  • Share

FDA Approves Immunotherapy Combo for Liver Cancer

A third of patients treated with Opdivo plus Yervoy experienced complete or partial tumor remission.

Drug Combo Improves Quality of Life for People With Liver Cancer

Tecentriq plus Avastin improved both overall survival and patient-reported outcomes.

Opdivo Shows Benefits for Liver Cancer but Falls Short of Survival Target

Immunotherapy led to fewer side effects and better quality of life than standard-of-care therapy.

FDA Approves Cyramza for Liver Cancer

There are now five targeted therapies for the most common type of liver cancer.

New Meds for Liver Cancer

Cabometyx is the third liver cancer drug approved in the past six months.

Rick George

Rough & Ready

Rick George credits his spiritual life with seeing him through multiple health crises, including liver cancer.

Nexavar

What Is Targeted Therapy?

Precision medicine matches patients with the treatments most likely to work for them.

Jens Ricke speaks at EASL International Liver Congress

Local Therapies With Nexavar Do Not Improve Liver Cancer Survival

Adding internal radiation or TACE did appear to help certain people, however.

Advertisement

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.